Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | JOHNSON & JOHNSON | $371.30B | $81.80B | $49.47B | $38.48B | $15.26 | 5.60% | 0.05% | 215.29% | 22.73% | 2024-05-29 | |
SNY | SANOFI | $123.50B | $49.94B | $14.09B | $5.81B | $2.32 | 6.87% | 4.70% | -32.73% | 3.84% | ||
AZN | ASTRAZENECA PLC | $238.85B | $47.61B | $14.25B | $6.33B | $2.05 | 8.60% | 16.27% | 34.98% | 16.57% | 2024-05-21 | |
LLY | ELI LILLY & CO | $732.88B | $35.93B | $9.13B | $6.14B | $6.82 | 29.76% | 10.69% | 8.08% | 1.57% | ||
NVS | NOVARTIS AG | $209.53B | $49.92B | N/A | $15.25B | $7.41 | 8.81% | 1.48% | 125.91% | 6.77% | 2024-06-20 | |
BIIB | BIOGEN INC | $33.49B | $9.66B | $1.85B | $1.17B | $8.05 | -4.37% | -6.89% | -62.80% | -19.14% | 2024-06-20 | |
GSK | GSK PLC | $90.75B | $37.95B | $7.29B | $5.54B | $2.73 | 12.47% | -1.11% | -67.61% | 1.40% | ||
ABBV | ABBVIE INC | $290.22B | $54.40B | $17.85B | $5.99B | $3.37 | -4.12% | 10.75% | -20.89% | -1.20% | ||
MRK | MERCK & CO INC | $331.49B | $61.40B | $8.97B | $2.31B | $0.91 | 6.11% | 7.35% | -82.26% | -22.24% | 2024-05-28 | |
AMGN | AMGEN INC | $168.83B | $29.53B | $12.07B | $3.76B | $7.04 | 12.76% | 4.45% | -52.46% | -11.00% | ||
GILD | GILEAD SCIENCES INC | $84.54B | $27.45B | $4.81B | $484.00M | $0.40 | 1.51% | 4.22% | -91.03% | -38.59% | 2024-06-12 | |
BMY | BRISTOL MYERS SQUIBB CO | $89.42B | $45.53B | $4.00B | -$6.15B | -$3.09 | -0.68% | 14.35% | N/A | N/A | ||
OGN | ORGANON & CO | $5.53B | $6.35B | $1.44B | $1.05B | $4.10 | 3.29% | N/A | 39.93% | N/A | 2024-06-04 | |
GRFS | GRIFOLS SA | $5.27B | $7.09B | $1.23B | $63.78M | $0.10 | 13.54% | 7.27% | -69.70% | -36.90% | 2024-06-14 | |
PFE | PFIZER INC | $163.88B | $55.09B | $4.69B | -$309.00M | -$0.05 | -40.86% | 6.07% | N/A | N/A | ||
SCLX | SCILEX HOLDING CO | $157.64M | $47.05M | -$101.67M | -$107.96M | -$1.31 | 12.54% | N/A | N/A | N/A | ||
AMRN | AMARIN CORP PLC | $374.71M | $277.46M | -$46.02M | -$52.61M | -$0.13 | -23.04% | 1.42% | N/A | N/A | ||
MIRA | MIRA PHARMACEUTICALS INC | $10.04M | $0.00 | -$8.95M | -$12.36M | -$0.67 | N/A | N/A | N/A | N/A |